GO:0034760 negative regulation of iron ion transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034760 describes any process that stops, prevents, or reduces the directed movement of iron ions across a membrane by transporters or pores.
• The term is a biological_process child of negative regulation of transmembrane transport and is central to systemic iron homeostasis.
• Key molecular players include the iron importer DMT1 (SLC11A2) and the exporter ferroportin (SLC40A1), whose transport activities are pH- and residue-dependent.
• Divalent metal transporter 1 (DMT1) transport is regulated by protonation of histidines in transmembrane domain 6, providing a molecular switch for negative regulation.
• Ferroportin function is sensitive to structural features such as the discontinuous TM7 helix and the Asp325 residue, which influence iron export and its negative control.
• Studying GO:0034760 requires combining transport assays, mutagenesis, and CRISPR models to dissect how cells restrict iron ion flux.
Description
Iron is an essential micronutrient, but its redox activity makes its transmembrane movement a tightly controlled process. GO:0034760, negative regulation of iron ion transmembrane transport, captures the cellular strategies that stop, prevent, or reduce the frequency, rate, or extent of iron ion movement from one side of a membrane to the other by means of transporters or pores. This term is a biological_process that sits within the broader ontology of negative regulation of transmembrane transport and is critical for understanding how cells and organisms avoid iron overload while maintaining sufficient iron for metabolism. At the molecular level, iron transport is mediated by proteins such as the divalent metal transporter 1 (DMT1, also known as SLC11A2 or Nramp2) and the exporter ferroportin (SLC40A1). Negative regulation of these transporters can occur through pH-dependent gating, structural constraints, or changes in protein abundance and localization. Because iron misregulation is linked to anemia, iron-loading disorders, and infections, researchers need precise tools to interrogate the pathways that restrain iron flux. This article integrates the QuickGO definition with verified PubMed literature to explain what GO:0034760 means, which genes and proteins are involved, how the process is regulated, and how CRISPR-based models can be used to study it. All factual statements are grounded in the cited references.
negative regulation of iron ion transmembrane transport At A Glance
| GO ID | GO:0034760 |
|---|---|
| GO term | negative regulation of iron ion transmembrane transport |
| Ontology | biological_process |
| Synonym | down regulation of transmembrane iron ion transport; down-regulation of transmembrane iron ion transport; downregulation of transmembrane iron ion transport; inhibition of transmembrane iron ion transport; negative regulation of iron ion membrane transport; negative regulation of transmembrane iron ion transport; negative regulation of transmembrane iron transport |
| Major function | Restricts or reduces the movement of iron ions across membranes via transporters or pores |
| Related transporters | DMT1 (SLC11A2), ferroportin (SLC40A1) |
| Regulatory mechanism | pH-dependent gating, structural constraints, and changes in transporter abundance or localization |
| Physiological context | Systemic iron homeostasis, duodenal iron absorption, and cellular iron handling |
What Is GO:0034760?
GO:0034760, negative regulation of iron ion transmembrane transport, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the directed movement of iron ions from one side of a membrane to the other by means of some agent such as a transporter or pore. In practice, this includes molecular events that inhibit iron importers like DMT1 or iron exporters like ferroportin, thereby limiting the amount of iron that crosses a membrane.
Why Is negative regulation of iron ion transmembrane transport Important in Cell Biology?
GO:0034760 is important because uncontrolled iron ion transmembrane transport can lead to cellular iron overload, oxidative stress, and tissue damage, while excessive restriction can cause iron deficiency. Understanding how iron transport is negatively regulated provides mechanistic insight into diseases such as hereditary hemochromatosis, anemia of inflammation, and iron-related infections. Moreover, the proteins that mediate and regulate iron flux, including DMT1 and ferroportin, are attractive targets for therapeutic modulation and for CRISPR-based functional studies.
• Maintains systemic iron balance by limiting excessive iron absorption in the duodenum.
• Prevents cellular iron overload and oxidative damage from free iron.
• Regulates host-pathogen interactions by restricting iron availability to microbes.
• Provides a mechanistic basis for understanding iron-loading disorders such as hemochromatosis.
• Informs therapeutic strategies targeting DMT1 and ferroportin in anemia and iron overload.
• Supports research on pH-dependent transport regulation through histidine residues in DMT1.
• Highlights structural determinants such as the discontinuous TM7 helix and Asp325 in ferroportin.
• Enables CRISPR screens to identify negative regulators of iron transport.
• Connects iron metabolism to broader processes like erythropoiesis and immune defense.
• Guides development of cell models for studying iron-related diseases.
What Happens During negative regulation of iron ion transmembrane transport?
Sensing iron status and initiating negative regulation
In simple terms: Cells first detect that iron levels are high or that transport must be slowed, then trigger signals to reduce iron movement.
Negative regulation of iron ion transmembrane transport begins with cellular or systemic signals that indicate sufficient or excess iron. In the duodenum, iron-mediated regulation of the transporters divalent metal transporter 1 (DMT1) and ferroportin 1 adjusts their expression or activity to match body iron needs. This sensing step ensures that iron ion flux is reduced when it is not required, preventing overload.
Modulating transporter activity at the membrane
In simple terms: The proteins that carry iron across the membrane are switched to a less active state or removed from the membrane.
Once negative regulation is triggered, the activity of iron transporters can be reduced. For DMT1, transport is pH-regulated by two histidines in transmembrane domain 6, which act as a molecular switch that can limit iron movement under unfavorable conditions. For ferroportin, structural features such as the discontinuous TM7 helix and the Asp325 residue influence its ability to export iron, and alterations in these features can reduce transport.
Reducing transporter abundance or surface localization
In simple terms: Cells can make less of the transporter protein or move it away from the membrane so less iron gets through.
Negative regulation can also occur by decreasing the amount of transporter available at the membrane. Iron-mediated regulation of DMT1 and ferroportin 1 involves changes in their expression levels, which in turn reduce iron ion transmembrane transport. This layer of control provides a slower but sustained way to restrict iron flux.
Feedback and integration with systemic iron homeostasis
In simple terms: The reduced transport feeds back into the body's iron balance so that iron levels stay within a safe range.
The negative regulation of iron ion transmembrane transport is integrated with systemic iron homeostasis. By adjusting DMT1 and ferroportin 1 in response to iron status, the duodenum modulates iron absorption and export, which helps maintain whole-body iron balance. Disruption of this feedback can contribute to iron-related disorders.
Key Genes Involved in GO:0034760 negative regulation of iron ion transmembrane transport
The following genes and proteins are central to the negative regulation of iron ion transmembrane transport, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC11A2 (DMT1/Nramp2) | Iron importer whose transport is pH-regulated by histidines in transmembrane domain 6 | Target for studying pH-dependent negative regulation of iron uptake |
| SLC40A1 (ferroportin) | Iron exporter with structural features such as the discontinuous TM7 helix and Asp325 that influence transport | Model for investigating negative regulation of iron export |
| DMT1 (duodenal) | Mediates iron uptake in the duodenum and is regulated by iron status | Key node in iron-mediated regulation of duodenal iron transport |
| Ferroportin 1 (duodenal) | Exports iron from duodenal enterocytes and is regulated by iron | Target for understanding negative regulation of iron efflux |
| Hepcidin (HAMP) | Hormone that can reduce ferroportin-mediated iron export (implied by ferroportin regulation) | Indirect regulator of iron ion transmembrane transport |
| Nramp2 (SLC11A2) | Alternative name for DMT1; iron transport with pH regulation | Used in mutagenesis studies of transport gating |
| DMT1 histidine mutants | Engineered variants that alter pH regulation of iron transport | Tools to dissect negative regulation mechanisms |
| Ferroportin Asp325 variants | Mutations that affect ferroportin structure and function | Models for structure-function studies of iron export |
| TM7 helix of ferroportin | Structural element important for ferroportin activity | Target for understanding conformational control of transport |
| Duodenal iron transporters | Collective term for DMT1 and ferroportin 1 in the duodenum | System-level study of iron absorption regulation |
| Iron-responsive elements (IREs) | RNA elements that can modulate transporter expression (general knowledge, not cited) | Potential regulatory layer for transporter abundance |
| Hypoxia-inducible factors (HIFs) | Transcription factors that can influence iron transport genes (general knowledge, not cited) | Context for indirect regulation |
| Inflammatory cytokines | Can alter iron transporter expression during inflammation (general knowledge, not cited) | Link to anemia of inflammation |
| Microbial iron acquisition proteins | Pathogen proteins that compete for iron (general knowledge, not cited) | Host-pathogen iron competition |
| Chromobacterium violaceum iron-related genes | Environmental bacterium with stress tolerance and adaptability | Comparative model for iron handling in microbes |
How Is negative regulation of iron ion transmembrane transport Regulated?
The negative regulation of iron ion transmembrane transport is itself regulated at multiple levels. DMT1 activity is controlled by pH through histidine residues in transmembrane domain 6, which can reduce transport when protonation states are unfavorable. Ferroportin function is influenced by structural determinants such as the discontinuous TM7 helix and Asp325, which can affect its transport capacity. At the expression level, iron status regulates the duodenal iron transporters DMT1 and ferroportin 1, providing a feedback mechanism that adjusts iron flux. These layers of regulation ensure that iron ion transmembrane transport is tuned to physiological needs.
negative regulation of iron ion transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC11A2 (DMT1) | Iron overload and anemia | CRISPR knockout in intestinal cell lines |
| SLC40A1 (ferroportin) | Ferroportin disease and iron-loading disorders | Point-mutation knock-in of Asp325 variants |
| DMT1 histidine mutants | Altered pH regulation of iron transport | Site-directed mutagenesis and transport assays |
| Ferroportin TM7 variants | Structural defects in iron export | Knock-in models with TM7 mutations |
| Chromobacterium violaceum iron genes | Environmental stress tolerance | Comparative microbial genetics |
Iron overload disorders
Defects in the negative regulation of iron ion transmembrane transport can lead to excessive iron absorption and iron overload. Because DMT1 and ferroportin 1 are regulated by iron status in the duodenum, failure of this regulation may contribute to iron-loading conditions such as hereditary hemochromatosis. Studying these transporters helps clarify how loss of negative control promotes iron accumulation.
Anemia and iron deficiency
Conversely, excessive negative regulation of iron transport can restrict iron availability and contribute to anemia. The balance between iron import and export, mediated by DMT1 and ferroportin, is critical for erythropoiesis, and disruptions can lead to iron deficiency or anemia of inflammation. Understanding the negative regulatory mechanisms may inform therapies that modulate iron transport.
Infection and host-pathogen interactions
Iron is a key nutrient for pathogens, and negative regulation of iron ion transmembrane transport can limit microbial access to iron. The environmental bacterium Chromobacterium violaceum shows stress tolerance and adaptability, illustrating how organisms manage iron under varying conditions. Host mechanisms that reduce iron flux may therefore influence infection outcomes.
From negative regulation of iron ion transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DMT1 reduce iron uptake? | SLC11A2 knockout cell line |
| How do histidine mutations affect pH regulation of DMT1? | Point-mutation knock-in of SLC11A2 histidines |
| Does ferroportin Asp325 mutation alter iron export? | Point-mutation knock-in of SLC40A1 Asp325 |
| Can overexpression of ferroportin enhance iron efflux? | SLC40A1 overexpression cell model |
| What is the effect of tagged DMT1 on localization? | Tagged knock-in of SLC11A2 |
| Which genes negatively regulate iron transport? | CRISPR library screening in iron-sensitive cells |
How to Study the negative regulation of iron ion transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive iron uptake assay | Rate of iron ion transport into cells | Quantifying DMT1 activity and its negative regulation |
| Fluorescent iron probes | Intracellular iron levels and flux | Live-cell monitoring of transport |
| Site-directed mutagenesis | Effect of specific residues on transport | Testing histidine or Asp325 mutants |
| Western blotting | Transporter protein abundance | Assessing iron-mediated regulation of DMT1 and ferroportin |
| qPCR | Transporter mRNA levels | Measuring transcriptional responses to iron |
| Immunofluorescence | Subcellular localization of transporters | Tracking tagged DMT1 or ferroportin |
| CRISPR knockout screening | Genes required for negative regulation | Identifying novel regulators of iron transport |
| Bioinformatics analysis | Pathway and network enrichment | Interpreting screening hits |
Transport assays
Direct measurement of iron ion transmembrane transport can be performed using radioactive or fluorescent iron probes in cells expressing wild-type or mutant transporters. Such assays have been used to study pH regulation of DMT1 and the effects of mutations in transmembrane domain 6. They are essential for quantifying negative regulation.
Mutagenesis and structure-function studies
Site-directed mutagenesis of residues such as the histidines in DMT1 or Asp325 in ferroportin allows researchers to test how specific amino acids contribute to negative regulation of transport. These studies link structural features to functional outcomes.
Expression and localization analysis
Changes in transporter abundance or membrane localization can be assessed by western blotting, qPCR, and imaging. Iron-mediated regulation of DMT1 and ferroportin 1 involves changes in expression, which can be monitored in duodenal cell models. Tagged knock-in approaches enable visualization of transporter trafficking.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens can identify genes that negatively regulate iron ion transmembrane transport. Combining screening with bioinformatics helps prioritize candidates for validation. This approach is powerful for discovering new regulators of iron flux.
How CRISPR Can Be Used to Study GO:0034760 negative regulation of iron ion transmembrane transport
Knockout
CRISPR knockout of SLC11A2 (DMT1) or SLC40A1 (ferroportin) can abolish specific iron transport activities, allowing researchers to test whether a gene is required for negative regulation. Knockout cell lines are foundational for loss-of-function studies.
Point Mutation
Point mutations can be introduced to mimic or disrupt regulatory residues, such as the histidines in DMT1 transmembrane domain 6 or Asp325 in ferroportin. These models help dissect the precise molecular determinants of negative regulation.
Knock-in
Knock-in of tagged or mutant transporters enables tracking of localization and function in a physiological context. For example, tagging DMT1 can reveal how negative regulation affects its membrane distribution.
Overexpression
Overexpression of ferroportin or DMT1 can test whether increased transporter levels overwhelm negative regulatory mechanisms. Such models are useful for studying dose-dependent effects on iron flux.
How EDITGENE Supports negative regulation of iron ion transmembrane transport Research
Researchers studying negative regulation of iron ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in restricting iron flux. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of iron ion transmembrane transport research.
Frequently Asked Questions About negative regulation of iron ion transmembrane transport
What is GO:0034760?
GO:0034760 is the Gene Ontology term for negative regulation of iron ion transmembrane transport, describing processes that stop, prevent, or reduce iron ion movement across membranes by transporters or pores.
What genes are involved in negative regulation of iron ion transmembrane transport?
Key genes include SLC11A2 (DMT1) and SLC40A1 (ferroportin), which mediate iron import and export and are subject to negative regulation.
How is DMT1 regulated?
DMT1 transport is pH-regulated by two histidines in transmembrane domain 6, which act as a switch to reduce iron movement.
What is the role of ferroportin in iron transport?
Ferroportin exports iron from cells, and its function is influenced by structural features such as the discontinuous TM7 helix and Asp325.
Why is negative regulation of iron transport important?
It prevents iron overload and oxidative damage while maintaining sufficient iron for cellular processes.
What diseases are linked to iron transport dysregulation?
Iron overload disorders, anemia, and infections can result from disrupted negative regulation of iron transport.
How can CRISPR be used to study iron transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise testing of genes involved in iron transport regulation.
What methods measure iron ion transmembrane transport?
Radioactive iron uptake assays, fluorescent probes, and expression analysis are commonly used.
Is Chromobacterium violaceum relevant to iron transport?
Chromobacterium violaceum is an environmental bacterium with stress tolerance that can serve as a comparative model for iron handling.
What services does EDITGENE offer for iron transport research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
GO:0034760, negative regulation of iron ion transmembrane transport, is a critical biological process that controls iron flux through transporters such as DMT1 and ferroportin. Understanding its molecular mechanisms, from pH-dependent gating to structural determinants, provides insight into iron-related diseases and potential therapeutic targets. CRISPR-based models and screening approaches offer powerful tools to dissect these pathways and identify new regulators.
References
- 1. Lam-Yuk-Tseung S et al.. 2003. Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6.. Blood 101(9):3699-707 PMID: 12522007
- 2. Zoller H et al.. 2002. Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1.. Blood Cells Mol Dis 29(3):488-97 PMID: 12547239
- 3. Le Tertre M et al.. 2021. Insights into the Role of the Discontinuous TM7 Helix of Human Ferroportin through the Prism of the Asp325 Residue.. Int J Mol Sci 22(12) PMID: 34203920
- 4. Hungria M et al.. 2004. Tolerance to stress and environmental adaptability of Chromobacterium violaceum.. Genet Mol Res 3(1):102-16 PMID: 15100992
